glp 1 agonist comparison Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials Corrination of a GLP-1 Receptor
Description
Diabetes Obes Metab (2020) 22:93846
Wael Mctabi and Dr
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION6): a randomised, openlabel study
These integrated actions position incretin-based therapies as uniquely suited to address the complex, multifactorial pathophysiology of MASLD [19]
